FcRH5/FcRL5 Protein, Human, Recombinant (His & Avi), Biotinylated

Catalog No. TMPK-01145 Copy Product Info

FcRH5 is a cell surface marker enriched on malignant plasma cells when compared to other hematologic malignancies and normal tissues. DFRF4539A is an anti-FcRH5 antibody-drug conjugated to monomethyl auristatin E (MMAE), a potent anti-mitotic agent. FcRH5/FcRL5 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with N-His-Avi tag. The predicted molecular weight is 94.19 kDa and the accession number is Q96RD9-1.

FcRH5/FcRL5 Protein, Human, Recombinant (His & Avi), Biotinylated

Catalog No. TMPK-01145

Copy Product Info

FcRH5/FcRL5 Protein, Human, Recombinant (His & Avi), Biotinylated

Pack Size	Price	USA Stock	Global Stock
5 μg	$115	7-10 days	7-10 days
10 μg	$188	7-10 days	7-10 days
20 μg	$313	7-10 days	7-10 days
50 μg	$622	7-10 days	7-10 days
100 μg	$1,050	-	In Stock
200 μg	$1,880	7-10 days	7-10 days
500 μg	$4,200	-	In Stock

Add to Cart

Add to Quotation

In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)

For research use only—not for human use. No sales to individuals. Use as intended only.

Questions

Batch Information

Select Batch

Resource Download

COA User Guide of Recombinant Proteins

Product Information

Biological Activity	Immobilized Anti-FcRH5 Antibody at 2μg/ml (100μl/well) on the plate. Dose response curve for Biotinylated Human FcRH5, His Tag with the EC50 of 72.0ng/ml determined by ELISA.
Description	FcRH5 is a cell surface marker enriched on malignant plasma cells when compared to other hematologic malignancies and normal tissues. DFRF4539A is an anti-FcRH5 antibody-drug conjugated to monomethyl auristatin E (MMAE), a potent anti-mitotic agent. FcRH5/FcRL5 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with N-His-Avi tag. The predicted molecular weight is 94.19 kDa and the accession number is Q96RD9-1.
Species	Human
Expression System	HEK293 Cells
Tag	N-His-Avi
Accession Number	Q96RD9-1
Synonyms	IFGP5,FLJ00397,FLJ00333,FcR-like protein 5,FcRL5,FCRH5MGC119593,FcRH5,DKFZp667F216,DKFZp667E2019,CD307e,CD307,BXMAS1MGC119592,BXMAS1
Construction	Gln16-Gly851
Protein Purity	> 95% as determined by Tris-Bis PAGE
Molecular Weight	94.19 kDa (predicted). Due to glycosylation, the protein migrates to 90-130 kDa based on Tris-Bis PAGE result.
Endotoxin	< 1.0 EU/μg of the protein as determined by the LAL method.
Formulation	Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS (pH 7.4). Typically, 8% trehalose is incorporated as a protective agent before lyophilization.
Reconstitution	Reconstitute the lyophilized protein in distilled water. The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing.
Stability & Storage	It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
Shipping	In general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice.
Research Background	FcRH5 is a cell surface marker enriched on malignant plasma cells when compared to other hematologic malignancies and normal tissues. DFRF4539A is an anti-FcRH5 antibody-drug conjugated to monomethyl auristatin E (MMAE), a potent anti-mitotic agent.